Predicta Biosciences - About the company
Predicta Biosciences is a series A company based in Boston (United States), founded in 2023 by Gad Getz, Irene Ghobrial and Ken Anderson. It operates as a Provider of diagnostic and therapeutic products for oncology. Predicta Biosciences has raised $28.6M in funding from Engine Ventures. The company has 102 active competitors, including 39 funded and 14 that have exited. Its top competitors include companies like Personalis, Epredia and Angle.
Company Details
Provider of diagnostic and therapeutic products for oncology. It offers a non-invasive diagnostics focus on multiple myeloma and evaluate patients’ immune system cells to determine the patient responding to immunotherapies.
Key Metrics
Founded Year
2023
Location
Boston, United States
Stage
Series A
Total Funding
$28.6M in 2 rounds
Latest Funding Round
Investors
Ranked
2nd among 102 active competitors
Employee Count
22 as on Sep 30, 2026
Similar Companies
Sign up to download Predicta Biosciences' company profile
Predicta Biosciences's funding and investors
Predicta Biosciences has raised a total funding of $28.6M over 2 rounds. Its first funding round was on Jul 16, 2024. Its latest funding round was a Series A round on Oct 01, 2025 for $*****. 6 investors participated in its latest round. Predicta Biosciences has 9 institutional investors.
Here is the list of recent funding rounds of Predicta Biosciences:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Oct 01, 2025 | 9906132 | Series A | 3616073 | 3937965 | 9784261 | 6679625 |
Jul 16, 2024 | 4042367 | Seed | 4739817 | 3992997 |
View details of Predicta Biosciences's funding rounds and investors
Predicta Biosciences' founders and board of directors
Founder? Claim ProfileThe founders of Predicta Biosciences are Gad Getz, Irene Ghobrial and Ken Anderson. Kate Caves is the CEO of Predicta Biosciences.
Here are the details of Predicta Biosciences' key team members:
- Gad Getz: Co-Founder of Predicta Biosciences.
- Irene Ghobrial: Co-Founder of Predicta Biosciences.
- Ken Anderson: Co-Founder of Predicta Biosciences.
- Kate Caves: CEO of Predicta Biosciences.
View details of Predicta Biosciences's Founder profiles and Board Members
Predicta Biosciences' employee count trend
Predicta Biosciences has 22 employees as of Sep 26. Here is Predicta Biosciences's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Predicta Biosciences's Competitors and alternates
Top competitors of Predicta Biosciences include Personalis, Epredia and Angle. Here is the list of Top 10 competitors of Predicta Biosciences, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Personalis 2011, Menlo Park (United States), Acquired | Provider of genomic sequencing and diagnosis software for the healthcare industry | $87.3M | 68/100 | |
2nd | Predicta Biosciences 2023, Boston (United States), Series A | Provider of diagnostic and therapeutic products for oncology | $28.6M | 59/100 | |
3rd | Epredia 2019, United Kingdom, Unfunded | Developer of in-vitro diagnostic test for cancer | - | - | 58/100 |
4th | Developer of cancer cell capture and analysis equipment | - | 57/100 | ||
5th | Xcell Biosciences 2012, San Francisco (United States), Series B | Developer of cell culture analysis device for cancer research | $40.9M | 56/100 | |
6th | Strata Oncology 2015, Ann Arbor (United States), Series C | Precision oncology company enabling smarter cancer treatment through advanced biomarker algorithms | $139M | 53/100 | |
7th | ACT Genomics 2014, Taipei (Taiwan), Acquired | Clinical and research services in genomics for cancer | $20.5M | 52/100 | |
8th | OncoPrecision 2020, Cordoba (Argentina), Seed | Developer of personalized assays for oncology precision therapy | $4.2M | 51/100 | |
9th | Ultivue 2015, Cambridge (United States), Series D | Provider of test panels for personalized cancer therapies | $105M | 51/100 | |
10th | PierianDx 2014, Saint Louis (United States), Acquired | Provider of genetic tests for individualized diagnosis of multiple diseases | $69.4M | 50/100 |
Looking for more details on Predicta Biosciences's competitors? Click here to see the top ones
Predicta Biosciences's Investments and acquisitions
Predicta Biosciences has made no investments or acquisitions yet.
Reports related to Predicta Biosciences
Here is the latest report on Predicta Biosciences's sector:
News related to Predicta Biosciences
Media has covered Predicta Biosciences for a total of 3 events in the last 1 year, 1 of them has been about company updates and 1 about partnerships.
•
Predicta Biosciences and CIMA LAB Diagnostics Announce Agreement to Advance Ultrasensitive Blood-Based Diagnostics for Multiple Myeloma and Other Hematological MalignanciesBusiness Wire•Jun 10, 2026•Predicta Biosciences
•
Predicta Biosciences Appoints Dr. Craig L. Tendler as Independent Director to its BoardBusiness Wire•May 20, 2026•Predicta Biosciences
•
•
Predicta Biosciences Completes $23.4 Million Series A Financing RoundGlobal Legal Chronicle•Oct 09, 2025•Predicta Biosciences
•
Predicta Biosciences Raises $23.4M in Series A FundingFinSMEs•Oct 02, 2025•BrightEdge, Predicta Biosciences, Mass General Brigham, Engine Ventures and 5 others
•
Predicta Biosciences Launches First Molecular Diagnostic ProductBusiness Wire•Apr 30, 2025•Predicta Biosciences
•
Predicta Biosciences Secures $5.2M to Transform the Diagnosis, Treatment and Monitoring of Blood CancersBusiness Wire•Jul 16, 2024•Predicta Biosciences, Engine Ventures, Illumina Ventures, Time Partners and 2 others
Are you a Founder ?
FAQs about Predicta Biosciences
Explore our recently published companies
- Vi2 Consulting - Thailand based, 2022 founded, Unfunded company
- VERV HQ - United States based, 2024 founded, Unfunded company
- Verticalize Creative - London based, 2021 founded, Unfunded company
- VERTIKAL ELEVADORES - Tomares based, 2008 founded, Unfunded company
- Verde Impacto - Nigeria based, Unfunded company
- Van Reis - Dallas based, 2025 founded, Unfunded company